Share this article
Share this article
DETROIT, May 11, 2021 /PRNewswire/ To dominate in a volatile market, you need education and insight into investment opportunities, and the
Benzinga Global Small Cap Conference will give you the information you need through our global showcase of small cap companies.
The conference, which takes place virtually on
May 13 - 14, kicks off with an exciting and information packed keynote from Jason Silva, TV Personality, Storyteller, and Filmmaker. Friday, May 14 kicks off with insights from Jake Brukhman, Founder & CEO of CoinFund and also an afternoon keynote with Kevin O Leary, AKA Mr. Wonderful. The agenda will highlight small cap companies across a wide range of industries including disruptive healthcare & finance, cannabis & psychedelics, and the new economy. Education on maximizing returns through active trading, how to trade healthcare and crypto stocks and the top psychedelic stocks to watch will be presented by expert traders.
Dried flower remains Canadians top pot purchase in 2020 with over $2B sold
Canadians bought more than $2 billion of dried flower cannabis products last year, while sales of edible products remained muted, according to Statistics Canada.
StatsCan s quarterly retail commodity survey showed dried flower continued to dominate the legal Canadian recreational market, accounting for more than three-quarters of all sales. Roughly $2.01 billion of dried flower, which also includes pre-rolls, were sold in 2020, with the fourth-quarter seeing nearly double the amount sold from the prior year with $614.4 million, according to StatsCan.
Interestingly, the next leading category was extracts and concentrates, which came in at $323.9 million sold last year, or 12.3 per cent of all sales. The category, which was only made available for legal sale in Oct. 2019, surged in retail activity with quarterly sales tripling by the fourth-quarter of the year to $123.7 million. Extract sale
Forward-Looking Information
This news release contains forward-looking information based on current expectations. Forward-looking information is provided for the purpose of presenting information about management’s current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. Forward looking information may include, without limitation, the Company’s ability to expand its product offerings to include concentrates and edibles in Massachusetts and Pennsylvania and to add meaningful wholesale revenue the success of TILT’s brand strategy, the receipt of any regulatory approvals, the anticipated growth of cannabis markets, the opinions or beliefs of management, prospects, opportunities, priorities, targets, goals, ongoing objectives, milestones, strategies and outlook of TILT, and includes statements about, among other things, future developments, the future operations, strengths and strategy of TILT.
CAC”). The Company intends to begin cultivation operations in the newly approved space later this month.
“We are pleased to announce the regulatory approval of the second phase of the planned expansion of our 117,000 sq ft cultivation and manufacturing facility in Taunton, Massachusetts,” said
Gary Santo, president of TILT. “We now have more than 56,000 sq. ft. of cultivation space with the ability to add a second grow tier to each of the eight new rooms, pending regulatory approval. Once planted, these additional rooms will fortify the supply of premium flower for our Taunton dispensary, and together with our award-winning kitchen and state-of-the art extraction and processing lab, will support the production and distribution of high-quality, consistent products for our brand partners. As we continue to solidify CAC’s presence in the state, we remain committed to working with the CCC to achieve final state licenses permitting medical dispensary operations at our Brockto